EVTcalc

Mechanical thrombectomy candidacy across the landmark trials — anterior & posterior circulation LVO

Clinical

SWIFT PRIME & EXTEND-IA enrolled only tPA-treated patients.

Non-contrast CT

CTA

CT Perfusion (RAPID) (optional)

Contact & feedback

Spotted a criterion that looks off, want a feature, or interested in collaborating? Send a note — it goes straight to the maintainer.

Your message is delivered privately to the maintainer. We never publish or share your email.

About & methodology

EVTcalc lets you enter a patient's clinical and CT/CTA findings once and see, at a glance, which landmark mechanical-thrombectomy trials that patient would have qualified for. It covers the early-window trials (MR CLEAN, ESCAPE, SWIFT PRIME, EXTEND-IA, REVASCAT), the extended-window trials (DEFUSE-3, DAWN), the large-core trials (RESCUE-Japan LIMIT, SELECT2, ANGEL-ASPECT), and the posterior-circulation trials (ATTENTION, BAOCHE).

Each trial is evaluated criterion by criterion against its published inclusion/exclusion rules. Every criterion resolves to pass, fail, or missing, and the trial verdict follows from those: Not eligible if any criterion fails, Insufficient data if nothing fails but a needed value is missing, and Meets criteria only when every criterion passes. To reduce clutter, trials the patient doesn't qualify for collapse to a one-line row showing the disqualifying reason; click any row to expand its full checklist.

Criteria are simplified in places, and those simplifications are noted on the individual trial cards (for example, this tool assumes CT/CTA-based selection, so RESCUE-Japan LIMIT's MRI-dependent late window is not scored). Perfusion fields are optional — trials that genuinely need a core volume show "insufficient data" rather than a false verdict when perfusion is left blank. Always verify against the primary publication linked on each card before acting.

EVTcalc is an independent educational tool and is not affiliated with, endorsed by, or connected to MDCalc.